Skip to main content
. 2011 Feb;36(2):78-80, 84-85, 107.

Table 5.

Cytochrome P450 3A4 Inhibitors

Amiodarone (Cordarone)
Aprepitant (Emend)
Atazanavir (Reyataz)
Caffeine
Cimetidine (Tagamet)
Clarithromycin (Biaxin)
Clotrimazole (Mycelex)
Conivaptan (Vaprisol)
Cyclosporine (Sandimmmune)
Delavirdine (Rescriptor)
Desipramine (Norpramin)
Diltiazem (Cardizem)
Doxycycline (Vibramycin)
Efavirenz (Sustiva)*
Erythromycin (e.g., E-mycin)
Fluconazole (Diflucan)
Fosamprenavir (Lexiva)
Fosaprepitant (Emend)
Fospropofol (Lusedra)
Haloperidol (Haldol)
Imatinib (Gleevec)
Indinavir (Crixivan)
Isoniazid (e.g., Nydrazid)
Itraconazole (Sporanox)
Ketoconazole (Nizoral)
Lidocaine (Xylocaine)
Metronidazole (Flagyl)
Miconazole (Monistat)
Nefazodone (Serzone)
Nelfinavir (Viracept)
Nicardipine (Cardene)
Norfloxacin (Noroxin)
Posaconazole (Noxafil)
Propofol (Diprivan)
Quinidine
Ritonavir (Norvir)
Saquinavir (Invirase)
Sertraline (Zoloft)
Sitaxsentan (Thelin)
Telithromycin (Ketek)
Tetracycline (e.g., Sumycin)
Verapamil (e.g., Calan)
Voriconazole (Vfend)

Adapted with permission from Lacy C, et al. Drug Information Handbook, 19th ed. 2010:1724–1730.9

*

Efavirenz is considered both a cytochrome P450 3A4 inhibitor and inducer.